← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity

TKNO logoAlpha Teknova, Inc.(TKNO)Earnings, Financials & Key Ratios

TKNO•NASDAQ
$3.64
$195M mkt cap·Price updated May 6, 2026
SectorHealthcareIndustrySpecialty & Generic PharmaSub-IndustryContract development and manufacturing services
AboutAlpha Teknova, Inc. provides critical reagents for life sciences market in the United States and internationally. Its reagents enable the discovery, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It serves life sciences market, including pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostic franchises, and academic and government research institutions. The company was founded in 1996 and is headquartered in Hollister, California.Show more
  • Revenue$41M+7.4%
  • EBITDA-$11M+45.7%
  • Net Income-$17M+35.5%
  • EPS (Diluted)-0.32+43.9%
  • Gross Margin33.17%+73.2%
  • EBITDA Margin-26.24%+49.4%
  • Operating Margin-41.9%+39.5%
  • Net Margin-42.59%+39.9%
  • ROE-22.83%+26.4%
  • ROIC-13.63%+30.2%
  • Debt/Equity0.22-39.9%
  • Interest Coverage-23.23+39.0%
Technical→

TKNO Key Insights

Alpha Teknova, Inc. (TKNO) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

No significant strengths identified

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Shares diluted 14.4% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

TKNO Price & Volume

Alpha Teknova, Inc. (TKNO) stock price & volume — 10-year historical chart

Loading chart...

TKNO Growth Metrics

Alpha Teknova, Inc. (TKNO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years5.3%
3 Years-0.73%
TTM9.29%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM26.29%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM36.24%

Return on Capital

10 Years-15.17%
5 Years-22.21%
3 Years-22.31%
Last Year-16.68%

TKNO Recent Earnings

Alpha Teknova, Inc. (TKNO) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 8/12 qtrs (67%)●Beat Revenue 9/12 qtrs (75%)
Q1 2026Latest
Feb 26, 2026
EPS
$0.09
Est $0.09
+0.0%
Revenue
$10M
Est $10M
+3.0%
Q4 2025
Nov 6, 2025
EPS
$0.08
Est $0.09
+14.7%
Revenue
$10M
Est $10M
+8.7%
Q3 2025
Aug 7, 2025
EPS
$0.07
Est $0.10
+30.3%
Revenue
$10M
Est $10M
+3.9%
Q2 2025
May 8, 2025
EPS
$0.09
Est $0.11
+18.2%
Revenue
$10M
Est $10M
-1.3%
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q1 2026LatestFeb 26, 2026
$0.09vs $0.09+0.0%
$10Mvs $10M+3.0%
Q4 2025Nov 6, 2025
$0.08vs $0.09+14.7%
$10Mvs $10M+8.7%
Q3 2025Aug 7, 2025
$0.07vs $0.10+30.3%
$10Mvs $10M+3.9%
Q2 2025May 8, 2025
$0.09vs $0.11+18.2%
$10Mvs $10M-1.3%
Based on last 12 quarters of dataView full earnings history →

TKNO Peer Comparison

Alpha Teknova, Inc. (TKNO) competitors in Contract development and manufacturing services — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
AZTA logoAZTAAzenta, Inc.Direct Competitor846.61M18.38-15.073.55%-29.86%-10.69%0.06
BRKR logoBRKRBruker CorporationDirect Competitor6.44B42.30-2822.08%-0.75%-1.11%0.81
NTRA logoNTRANatera, Inc.Direct Competitor29.58B215.09-140.5856.75%-14.61%-24.69%0.16
PACB logoPACBPacific Biosciences of California, Inc.Direct Competitor516.17M1.71-1.60-23.19%-325.8%-13.95%1.33
FLGT logoFLGTFulgent Genetics, Inc.Direct Competitor443.83M14.92-7.5713.83%-18.75%-5.42%0.00
CRL logoCRLCharles River Laboratories International, Inc.Product Competitor8.97B181.73-62.45-0.85%-3.59%-4.34%0.95
MEDP logoMEDPMedpace Holdings, Inc.Product Competitor12.19B426.7927.9319.97%17.19%120.89%0.55
ICLR logoICLRICON Public Limited CompanyProduct Competitor9.48B124.1313.031.99%7.4%6.32%0.38

Compare TKNO vs Peers

Alpha Teknova, Inc. (TKNO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs AZTA

Most directly comparable listed peer for TKNO.

Scale Benchmark

vs TMO

Larger-name benchmark to compare TKNO against a more recognizable public peer.

Peer Set

Compare Top 5

vs AZTA, BRKR, NTRA, PACB

TKNO Income Statement

Alpha Teknova, Inc. (TKNO) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Sales/Revenue20.09M31.3M36.89M41.42M36.68M37.74M40.52M41.8M
Revenue Growth %-55.75%17.88%12.27%-11.43%2.89%7.35%9.29%
Cost of Goods Sold11.52M13.54M19.27M23.94M26.39M30.51M27.08M27.58M
COGS % of Revenue57.33%43.27%52.24%57.81%71.93%80.84%66.83%-
Gross Profit
8.57M▲ 0%
17.75M▲ 107.1%
17.62M▼ 0.8%
17.48M▼ 0.8%
10.3M▼ 41.1%
7.23M▼ 29.8%
13.44M▲ 85.9%
14.22M▲ 0%
Gross Margin %42.67%56.73%47.76%42.19%28.07%19.16%33.17%34.01%
Gross Profit Growth %-107.08%-0.75%-0.82%-41.08%-29.77%85.88%-
Operating Expenses10.43M13.09M29.63M67.14M45.86M33.38M30.42M30.24M
OpEx % of Revenue51.91%41.83%80.31%162.08%125.01%88.43%75.07%-
Selling, General & Admin8.56M10.44M24.17M37.45M34.78M29.47M27.07M27.13M
SG&A % of Revenue42.6%33.35%65.51%90.41%94.81%78.08%66.81%-
Research & Development769K1.51M4.31M7.74M5.57M2.76M2.2M2.25M
R&D % of Revenue3.83%4.82%11.69%18.68%15.18%7.31%5.42%-
Other Operating Expenses1.1M1.15M1.15M21.95M5.51M1.15M1.15M861K
Operating Income
-1.86M▲ 0%
4.66M▲ 351.2%
-12.01M▼ 357.5%
-49.66M▼ 313.5%
-35.56M▲ 28.4%
-26.15M▲ 26.5%
-16.98M▲ 35.1%
-16.31M▲ 0%
Operating Margin %-9.24%14.9%-32.55%-119.89%-96.94%-69.27%-41.9%-39.02%
Operating Income Growth %-351.24%-357.52%-313.55%28.39%26.48%35.07%-
EBITDA-233K6.71M-9.13M-46.49M-29.9M-19.57M-10.63M-11.55M
EBITDA Margin %-1.16%21.43%-24.73%-112.25%-81.52%-51.84%-26.24%-27.63%
EBITDA Growth %-2978.54%-236.05%-409.52%35.68%34.56%45.66%30.44%
D&A (Non-Cash Add-back)1.62M2.04M2.88M3.17M5.66M6.58M6.34M4.76M
EBIT-1.86M4.66M-12.01M-28.86M-31.2M-26.15M-16.49M-12.01M
Net Interest Income66K87K-589K213K-833K-687K-710K-566K
Interest Income66K87K0213K0000
Interest Expense00589K0833K687K710K347K
Other Income/Expense56K63K-629K268K-1.51M-687K-225K-776K
Pretax Income
-1.8M▲ 0%
4.73M▲ 362.6%
-12.64M▼ 367.4%
-49.39M▼ 290.8%
-37.08M▲ 24.9%
-26.83M▲ 27.6%
-17.2M▲ 35.9%
-17.09M▲ 0%
Pretax Margin %-8.96%15.1%-34.25%-119.24%-101.07%-71.09%-42.45%-40.87%
Income Tax-495K1.16M-2.83M-1.92M-298K-88K58K83K
Effective Tax Rate %27.5%24.46%22.43%3.89%0.8%0.33%-0.34%-0.49%
Net Income
-1.3M▲ 0%
3.57M▲ 373.6%
-9.8M▼ 374.6%
-47.47M▼ 384.2%
-36.78M▲ 22.5%
-26.75M▲ 27.3%
-17.26M▲ 35.5%
-17.17M▲ 0%
Net Margin %-6.49%11.41%-26.57%-114.6%-100.26%-70.86%-42.59%-41.07%
Net Income Growth %-373.56%-374.59%-384.22%22.52%27.28%35.47%26.29%
Net Income (Continuing)-1.3M3.57M-9.8M-47.47M-36.78M-26.75M-17.26M-17.17M
Discontinued Operations00000000
Minority Interest00000000
EPS (Diluted)
-0.36▲ 0%
0.16▲ 144.4%
-0.35▼ 318.8%
-1.69▼ 382.9%
-1.16▲ 31.4%
-0.57▲ 50.9%
-0.32▲ 43.9%
-0.32▲ 0%
EPS Growth %-144.44%-318.75%-382.86%31.36%50.86%43.86%36.24%
EPS (Basic)-0.050.03-0.35-1.69-1.16-0.57-0.32-
Diluted Shares Outstanding3.64M3.98M28.01M28.08M31.82M46.75M53.48M53.61M
Basic Shares Outstanding26.11M21.11M28.01M28.08M31.82M46.75M53.48M53.61M
Dividend Payout Ratio--------

TKNO Balance Sheet

Alpha Teknova, Inc. (TKNO) balance sheet — assets, liabilities & shareholders' equity

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Total Current Assets15.42M16.41M101.2M61.14M45.66M42.78M34.51M31.67M
Cash & Short-Term Investments9.68M5.13M87.52M42.24M28.48M30.4M5.91M4.31M
Cash Only4.14M3.31M87.52M42.24M28.48M3.71M5.91M4.31M
Short-Term Investments5.53M1.81M00026.69M00
Accounts Receivable2.99M6.57M5.85M4.28M3.95M4.31M4.62M5.67M
Days Sales Outstanding54.2476.6157.9237.7439.2841.741.644.89
Inventory2.57M3.58M5.39M12.25M11.59M6.8M7.05M6.87M
Days Inventory Outstanding81.396.55102.16186.69160.3781.3595.0894.12
Other Current Assets01.14M001.63M1.27M16.93M14.82M
Total Non-Current Assets43.09M46.5M65.31M91.12M82.93M75.99M69.07M66.98M
Property, Plant & Equipment5.45M10.01M29.81M71.31M66.84M61.52M55.84M54.13M
Fixed Asset Turnover3.69x3.13x1.24x0.58x0.55x0.61x0.73x0.74x
Goodwill16.61M16.61M16.61M00000
Intangible Assets21M19.85M18.7M17.56M14.24M13.09M11.94M11.66M
Long-Term Investments00000000
Other Non-Current Assets32K24K180K2.25M1.85M1.38M1.28M5.14M
Total Assets
58.51M▲ 0%
62.91M▲ 7.5%
166.51M▲ 164.7%
152.26M▼ 8.6%
128.59M▼ 15.5%
118.77M▼ 7.6%
103.58M▼ 12.8%
98.66M▲ 0%
Asset Turnover0.34x0.50x0.22x0.27x0.29x0.32x0.39x0.40x
Asset Growth %-7.52%164.68%-8.56%-15.55%-7.64%-12.79%-43.73%
Total Current Liabilities5.58M3.96M7.74M10.88M8.88M11.21M7.54M6.9M
Accounts Payable768K1.64M2.25M2.45M1.49M825K1.38M1.62M
Days Payables Outstanding24.3344.0742.5837.3320.659.8718.5717.48
Short-Term Debt45K00004.04M1.88M1.92M
Deferred Revenue (Current)00200K198K16K30K05K
Other Current Liabilities0845K00004.28M4.98M
Current Ratio2.76x4.14x13.07x5.62x5.14x3.82x4.58x4.58x
Quick Ratio2.30x3.24x12.37x4.50x3.84x3.21x3.64x3.64x
Cash Conversion Cycle111.21129.09117.5187.1179113.18118.11121.53
Total Non-Current Liabilities40.02M6.54M15.56M41.5M29.68M25.16M27.27M26.84M
Long-Term Debt0011.87M21.98M13.25M9.44M13.27M12.74M
Capital Lease Obligations00018.11M15.4M14.88M014.05M
Deferred Tax Liabilities3.9M5.99M3.15M1.22M919K827K879K3.62M
Other Non-Current Liabilities36.12M554K542K191K102K10K13.12M39.37M
Total Liabilities45.6M10.51M23.31M52.38M38.55M36.38M34.81M33.73M
Total Debt45K011.87M42.31M30.46M30.17M15.15M14.66M
Net Debt-4.1M-3.31M-75.65M74K1.97M26.46M9.23M10.35M
Debt / Equity0.00x-0.08x0.42x0.34x0.37x0.22x0.22x
Debt / EBITDA--------1.27x
Net Debt / EBITDA--0.49x------0.90x
Interest Coverage---20.39x--37.45x-38.06x-23.23x-34.62x
Total Equity
12.91M▲ 0%
52.41M▲ 305.9%
143.2M▲ 173.3%
99.89M▼ 30.2%
90.04M▼ 9.9%
82.39M▼ 8.5%
68.78M▼ 16.5%
64.92M▲ 0%
Equity Growth %-305.93%173.26%-30.25%-9.86%-8.49%-16.53%-54.32%
Book Value per Share3.5513.185.113.562.831.761.291.21
Total Shareholders' Equity12.91M52.41M143.2M99.89M90.04M82.39M68.78M64.92M
Common Stock000001K1K1K
Retained Earnings-1.3M2.27M-7.54M-55.01M-91.79M-118.53M-135.79M-140.34M
Treasury Stock00000000
Accumulated OCI20K7K000000
Minority Interest00000000

TKNO Cash Flow Statement

Alpha Teknova, Inc. (TKNO) cash flow — operating, investing & free cash flow history

Line itemDec'19Dec'20Dec'21Dec'22Dec'23Dec'24Dec'25TTM
Cash from Operations2.17M2.5M-9.07M-27.4M-18.81M-12.39M-8.65M-8.08M
Operating CF Margin %10.81%8%-24.58%-66.15%-51.29%-32.83%-21.34%-
Operating CF Growth %-15.33%-462.04%-202.13%31.34%34.14%30.22%196.63%
Net Income-1.3M3.57M-9.8M-47.47M-36.78M-26.75M-17.26M-17.17M
Depreciation & Amortization1.62M2.04M2.88M3.17M5.66M6.58M6.34M6.34M
Stock-Based Compensation0300K1.55M3.71M4.14M3.67M2.58M2.42M
Deferred Taxes-457K2.09M-2.84M-1.93M-304K-92K52K77K
Other Non-Cash Items12K7K906K22.46M6.22M5.08M2.32M4.88M
Working Capital Changes2.3M-5.51M-1.77M-7.33M2.25M-873K-2.68M-893K
Change in Receivables-104K-2.35M-49K380K314K-494K-374K-86K
Change in Inventory996K-987K-2.25M-7.55M330K244K-2.37M-1.75M
Change in Payables1.19M-89K270K572K-773K-594K470K60K
Cash from Investing-8.16M-1.74M-17.52M-28.15M-7.74M-27.27M10.7M8.72M
Capital Expenditures-2.65M-5.47M-19.88M-28.15M-7.93M-1.13M-1.15M-1.16M
CapEx % of Revenue13.18%17.46%53.88%67.96%21.63%2.98%2.83%-
Acquisitions00000000
Investments--------
Other Investing61K27K529K0197K125K00
Cash from Financing8.57M-1.6M110.79M10.27M12.8M14.89M151K-85K
Debt Issued (Net)-847K-45K11.89M10.13M-10M02.3M2.24M
Equity Issued (Net)16.17M0102.67M439K22.83M15.1M211K135K
Dividends Paid00000000
Share Repurchases-19.47M0000000
Other Financing-6.75M-1.55M-3.77M-307K-32K-214K-2.36M-2.46M
Net Change in Cash
2.59M▲ 0%
-829K▼ 132.1%
84.2M▲ 10257.2%
-45.28M▼ 153.8%
-13.75M▲ 69.6%
-24.78M▼ 80.2%
2.2M▲ 108.9%
929K▲ 0%
Free Cash Flow
-477K▲ 0%
-2.96M▼ 520.8%
-28.95M▼ 877.6%
-55.55M▼ 91.9%
-26.75M▲ 51.8%
-13.52M▲ 49.5%
-9.23M▲ 31.7%
-5.51M▲ 0%
FCF Margin %-2.37%-9.46%-78.46%-134.11%-72.91%-35.81%-22.78%-13.17%
FCF Growth %--520.75%-877.58%-91.91%51.85%49.47%31.7%50.75%
FCF per Share-0.13-0.74-1.03-1.98-0.84-0.29-0.17-0.17
FCF Conversion (FCF/Net Income)-1.66x0.70x0.93x0.58x0.51x0.46x0.50x0.32x
Interest Paid59K36K414K001.55M1.46M369K
Taxes Paid95K323K8K0039K2K34K

TKNO Key Ratios

Alpha Teknova, Inc. (TKNO) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric202020212022202320242025TTM
Return on Equity (ROE)10.93%-10.02%-39.05%-38.73%-31.02%-22.83%-24.32%
Return on Invested Capital (ROIC)12.08%-15.44%-44.47%-27.79%-19.52%-13.63%-13.63%
Gross Margin56.73%47.76%42.19%28.07%19.16%33.17%34.01%
Net Margin11.41%-26.57%-114.6%-100.26%-70.86%-42.59%-41.07%
Debt / Equity-0.08x0.42x0.34x0.37x0.22x0.22x
Interest Coverage--20.39x--37.45x-38.06x-23.23x-34.62x
FCF Conversion0.70x0.93x0.58x0.51x0.46x0.50x0.32x
Revenue Growth55.75%17.88%12.27%-11.43%2.89%7.35%9.29%

TKNO SEC Filings & Documents

Alpha Teknova, Inc. (TKNO) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 6, 2026·SEC

Material company update

Feb 26, 2026·SEC

Material company update

Nov 6, 2025·SEC

10-K Annual Reports

5
FY 2026

Mar 2, 2026·SEC

FY 2025

Mar 7, 2025·SEC

FY 2024

Mar 27, 2024·SEC

10-Q Quarterly Reports

6
FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 8, 2025·SEC

FY 2025

May 9, 2025·SEC

TKNO Frequently Asked Questions

Alpha Teknova, Inc. (TKNO) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Alpha Teknova, Inc. (TKNO) reported $41.8M in revenue for fiscal year 2025. This represents a 108% increase from $20.1M in 2019.

Alpha Teknova, Inc. (TKNO) grew revenue by 7.4% over the past year. This is steady growth.

Alpha Teknova, Inc. (TKNO) reported a net loss of $17.2M for fiscal year 2025.

Dividend & Returns

Alpha Teknova, Inc. (TKNO) has a return on equity (ROE) of -22.8%. Negative ROE indicates the company is unprofitable.

Alpha Teknova, Inc. (TKNO) had negative free cash flow of $5.5M in fiscal year 2025, likely due to heavy capital investments.

Explore More TKNO

Alpha Teknova, Inc. (TKNO) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.